NEW YORK (GenomeWeb News) – DiscoveRx today said that it has acquired BioSeek, maker of the BioMAP platform of cell-based disease models for drug screening.
Financial terms of the deal were not disclosed.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Compugen and DiscoveRx today announced a collaboration to commercialize specially designed peptides matched with specific G protein-coupled receptor targets.

By Adam Bonislawski
Two papers published in the current edition of Nature Biotechnology add significantly to the publicly available data on the specificity of kinase inhibitors.

Starting in the first quarter of 2011, DiscoveRx plans to add its own panel of cell-based assays to the KinomeScan service as an offering.

The co-marketing agreement will give Jubilant’s drug developer customers cell-based screening services.

BioFocus will offer DiscoveRx's GPCR and cAMP assays as part of its screening services.

DiscoveRx will provide GSK with access to its beta-arresting parental cell lines, clones, and associated reagents.

Under a proposed spending bill, the US National Institutes of Health would see an additional $3 billion in funding.

Researchers from the University of Oxford and the University of Sydney sequenced numerous platypus genomes to study their population history.

Robert Redfield, the new pick to lead the US Centers for Disease Control and Prevention, has faced criticism for some of his work.

In Nature this week: sequenced genomes of five additional Neanderthals, and more.